SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Nephrology Consultation — Booker T. Washington

PatientBooker T. Washington
Date of birth1967-04-05
IdentifiersMRN HR-NI017-SYN; SSN (made up) 000-17-2284
Document date2026-05-11
AuthorDesmond Oyelaran, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Severe hypertension with chronic kidney disease stage G3b and severely increased albuminuria in a 59-year-old man. Please assess the cause of the kidney disease, advise on kidney-protective therapy and blood pressure targets, and share his long-term care. [S]

Urgency: Soon, within one week; kidney ultrasound and echocardiogram booked for the morning of the consultation. [S]

Questions for the consultant:

History of Present Illness

Mr. Washington is seen at the request of Dr. Whitfield one week after presenting with headaches, palpitations, fatigue, and a blood pressure of 212/128 mmHg. On amlodipine and losartan his home readings have fallen to the 160s and 170s over 100s, he has had one mild headache this week, and his palpitations are less frequent. He has had no chest pain, breathlessness, weakness, confusion, or sudden change in vision, and no lightheadedness on standing or ankle swelling. He gets up twice a night to urinate and has seen no blood in the urine. He takes no NSAIDs or other over-the-counter products. He travels often for work and wants a plan that he can keep on the road. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

5 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Medications

MedicationFrequencyRouteDatesStatusEvidence
Amlodipine 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-05-04activeS
Losartan 50 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-05-04 to 2026-05-11completedS
Losartan 100 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-05-11activeS
Dapagliflozin 10 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-05-11activeS
Atorvastatin 20 mg oral tablet, one tablet by mouth dailyOne tablet by mouth dailyOral route2026-05-04activeS

Problems

ProblemClinical statusVerificationCodeProvenance
Severe hypertension with hypertensive kidney disease; synthetic modern diagnosis linked to the documented 1915 blood pressure of 220/150activeconfirmed I12.9S — Synthetic active diagnosis for the teaching episode; the 1915 findings remain D and the retrospective diagnosis remains R.
Chronic kidney disease stage G3b A3 (severely increased albuminuria), attributed to hypertensive nephrosclerosisactiveconfirmed N18.32S — Synthetic diagnosis supported by small echogenic kidneys and albuminuria; linked to the documented 1915 diagnosis of Bright's disease.
Hypertensive retinopathy, both eyes, without papilledemaactiveconfirmed H35.033S — Synthetic funduscopic finding that echoes the documented failing vision.
Mild anemia of chronic kidney disease, iron replete; monitoractiveconfirmed D63.1S — Synthetic finding from the baseline hemoglobin and iron studies.
Hyperlipidemiaactiveconfirmed E78.5S — Synthetic finding from the baseline LDL cholesterol.

Physical Exam

Vital signs recorded on 2026-05-11; see the referring visit's Vital Signs section. [S]

SystemFinding
GeneralAlert, articulate, and in no distress
Blood pressure172/104 mmHg, the average of two seated readings after five minutes of rest
EyesArteriolar narrowing on undilated funduscopy; no hemorrhages or papilledema
HeartRegular rhythm, rate 82; S4; no murmur
LungsClear
AbdomenNo abdominal bruit
ExtremitiesNo edema

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-05-11Sodium [Moles/volume] in Serum or Plasma138mmol/L135-145 mmol/LNormalS
2026-05-11Potassium [Moles/volume] in Serum or Plasma4.6mmol/L3.5-5.1 mmol/LNormalS
2026-05-11Carbon dioxide, total [Moles/volume] in Serum or Plasma22mmol/L22-29 mmol/LNormalS
2026-05-11Urea nitrogen [Mass/volume] in Serum or Plasma36mg/dL6-24 mg/dLHighS
2026-05-11Creatinine [Mass/volume] in Serum or Plasma2.2mg/dL0.74-1.35 mg/dLHighS
2026-05-11Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M34mL/min/{1.73_m2}>=60 mL/min/1.73 m²LowS
2026-05-11Glucose [Mass/volume] in Serum or Plasma95mg/dL70-99 mg/dLNormalS
2026-05-11Left ventricular Ejection fraction60%50-70%NormalS

Assessment

Data reviewed: Today's kidney ultrasound: both kidneys small (9.4 and 9.6 cm) and echogenic, symmetric, without hydronephrosis. Today's echocardiogram: concentric left ventricular hypertrophy, ejection fraction 60 percent. Last week's ECG and dilated funduscopic examination. Both basic metabolic panels, the urine albumin-creatinine ratio, mineral studies, blood count, and iron studies. No urinalysis with microscopy is on file. [S]

Plan of Treatment